Mark E. Newman's Insider Trades & SAST Disclosures
Mark E. Newman's most recent trade in Chemours Company was a trade of 7,661 Common Stock done at an average price of $32.6 . Disclosure was reported to the exchange on June 9, 2023.
Add Superstar Alert
Note
This is a custom search result for pattern Mark E. Newman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 32.63 per share. | 09 Jun 2023 | 7,661 | 266,954 (0%) | 0% | 32.6 | 249,978 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 100,200 | 100,200 | - | - | Performance Stock Option (Right to Buy) | |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 147,540 | 292,224 (0%) | 0% | 0 | Common Stock | |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.35 per share. | 10 Feb 2023 | 70,974 | 221,250 (0%) | 0% | 34.4 | 2,437,957 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 40.22 per share. | 05 May 2022 | 197,161 | 176,347 (0%) | 0% | 40.2 | 7,929,815 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.04 per share. | 05 May 2022 | 197,161 | 373,508 (0%) | 0% | 16.0 | 3,162,462 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2022 | 197,161 | 0 | - | - | Stock Option (Right to Buy) | |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 206,268 | 206,268 | - | - | Stock Option (Right to Buy) | |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 19,630 | 176,253 (0%) | 0% | 0 | Common Stock | |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.98 per share. | 01 Mar 2022 | 1,253 | 156,623 (0%) | 0% | 26.0 | 32,553 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 19,473 | 165,010 (0%) | 0% | 0 | Common Stock | |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.00 per share. | 11 Feb 2022 | 7,133 | 157,877 (0%) | 0% | 30 | 213,990 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 34,252 | 0 | - | - | Stock Option (Right to Buy) | |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 02 Dec 2021 | 34,252 | 179,710 (0%) | 0% | 18.4 | 631,949 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 29.94 per share. | 02 Dec 2021 | 34,252 | 145,458 (0%) | 0% | 29.9 | 1,025,505 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2021 | 3,691 | 34,252 | - | - | Stock Option (Right to Buy) | |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 30 Aug 2021 | 3,691 | 145,377 (0%) | 0% | 35 | 129,185 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 30 Aug 2021 | 3,691 | 149,068 (0%) | 0% | 18.5 | 68,099 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2021 | 29,732 | 37,943 | - | - | Stock Option (Right to Buy) | |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 27 Aug 2021 | 29,732 | 145,377 (0%) | 0% | 35 | 1,040,620 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 27 Aug 2021 | 29,732 | 175,109 (0%) | 0% | 18.4 | 548,555 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 34,696 | 34,696 | - | - | Stock Option (Right to Buy) | |
|
Chemours Company
|
Mark E. Newman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 3,948 | 145,377 (0%) | 0% | 0 | Common Stock | |
|
Altria Group Inc.
Dividend |
Mark E. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 3,517 | 22,604 (0%) | 0% | 0 | Common Stock | |
|
Chemours Company
|
Mark E. Newman | Senior VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 61,349 | 61,349 | - | - | Stock Option (Right to Buy) | |
|
Chemours Company
|
Mark E. Newman | Senior VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 6,247 | 141,271 (0%) | 0% | 0 | Common Stock | |
|
Chemours Company
|
Mark E. Newman | Senior VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 2,868 | 136,212 (0%) | 0% | 0 | Common Stock | |
|
Chemours Company
|
Mark E. Newman | Senior VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.14 per share. | 12 Feb 2021 | 1,188 | 135,024 (0%) | 0% | 26.1 | 31,054 | Common Stock |
|
Altria Group Inc.
Dividend |
Mark E. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2020 | 4,866 | 18,079 (0%) | 0% | 0 | Common Stock | |
|
Chemours Company
|
Mark E. Newman | Senior VP & COO | Purchase of securities on an exchange or from another person at price $ 11.62 per share. | 07 May 2020 | 1,500 | 132,344 (0%) | 0% | 11.6 | 17,428 | Common Stock |
|
Chemours Company
|
Mark E. Newman | Senior VP & COO | Purchase of securities on an exchange or from another person at price $ 11.62 per share. | 07 May 2020 | 1,000 | 133,344 (0%) | 0% | 11.6 | 11,620 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges